chr3-10142055-G-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PVS1PM2_SupportingPS4_Moderate
This summary comes from the ClinGen Evidence Repository: The variant NM_000551.3(VHL):c.208G>T (p.Glu70Ter) variant in VHL is a truncating variant. This variant causes a premature stop codon in a biologically-relevant-exon leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1_Met). The variant has been reported in 6 unrelated probands and/or families meeting either VHL Type 1 or affected with VHL-related cancers. CIViC Evidence IDs (https://civicdb.org): 9266,5361,5445,5035,6059,8209 and PMIDs: 18446368, 8707293, 20660572, 9829911, 7728151, 11148816. (PS4_Moderate)There is one variant present in gnomAD v4.1.0. The GroupMax Filtering Allele Frequency (95% CI) in gnomAD v4.1.0 is not calculated. PM2_Supporting can be applied for variants with <= 0.0000015 (0.00015%) frequency in gnomAD, or if no GroupMax Filtering Allele Frequency is calculated (due to a single variant present) (PM2_Supporting). In summary, this variant meets the criteria to be classified as Pathogenic for autosomal-dominant von Hippel-Lindau syndrome (VHL syndrome) based on the ACMG/AMP criteria applied, as specified by the ClinGen VHL VCEP Version 1.0 (Specifications approval date: 02/26/2024. Variant Approval Date 06/25/2024). LINK:https://erepo.genome.network/evrepo/ui/classification/CA16602179/MONDO:0008667/078
Frequency
Consequence
NM_000551.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- pheochromocytomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- von Hippel-Lindau diseaseInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, ClinGen, Genomics England PanelApp, G2P
- renal cell carcinomaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- autosomal recessive secondary polycythemia not associated with VHL geneInheritance: AR Classification: STRONG Submitted by: Ambry Genetics
- Chuvash polycythemiaInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000551.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| VHL | MANE Select | c.208G>T | p.Glu70* | stop_gained | Exon 1 of 3 | NP_000542.1 | A0A024R2F2 | ||
| VHL | c.208G>T | p.Glu70* | stop_gained | Exon 1 of 3 | NP_001341652.1 | A0A8Q3WL21 | |||
| VHL | c.208G>T | p.Glu70* | stop_gained | Exon 1 of 2 | NP_937799.1 | A0A0S2Z4K1 |
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| VHL | TSL:1 MANE Select | c.208G>T | p.Glu70* | stop_gained | Exon 1 of 3 | ENSP00000256474.3 | P40337-1 | ||
| VHL | TSL:1 | c.208G>T | p.Glu70* | stop_gained | Exon 1 of 2 | ENSP00000344757.2 | P40337-2 | ||
| VHL | TSL:1 | n.254G>T | non_coding_transcript_exon | Exon 1 of 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.88e-7 AC: 1AN: 1453984Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 723244 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at